Description

The purpose of the session is to demonstrate the integral role of research and registries for providing evidence required for insurance coverage of new imaging technology and of existing technology for expanded indications. Several case studies will highlight the role of advocacy for educating policy makers about the need for new coverage rules. Participants also will learn the perspective of private insurers regarding the criteria for determining coverage policies. The information presented will be applicable to all imaging sub-specialties and modalities.

Learning Objectives:

1. Describe how Medicare's "Coverage with Evidence Development" initiatives affect policy decision making.
2. Discuss the role of advocacy in influencing new coverage decisions.
3. Describe how clinical practices can contribute to new coverage decisions.

Subspecialties

• Thoracic

Modalities

• Computer Tomography, Nuclear Medicine, PET/CT

Speaker(s):

• Naomi Aronson, Ph.D
• Laurie Fenton Ambrose
• Bruce Hillner, MD
• Ella Kazerooni, MD, MS, FACR FSCBTMR
• Cynthia Moran, BA

Moderator(s):

• Ruth Carlos, MD, MS, FACR
• Pamela Woodard, MD, FACR

Disclosures

• Ruth Carlos, MD, MS, FACR : <p>Ruth Carlos: Salary-JACR/ACR</p>
• Pamela Woodard, MD, FACR : <p>Pamela Woodard: Consultant-Medtronic, Inc.; Research Grants-Siemens Medical Solutions USA, Inc.|Guerbet|Astellas|Biotronik|Bayer Healthcare</p>
• Ella Kazerooni, MD, MS, FACR FSCBTMR : <p>Ella Kazerooni: None</p>
• Naomi Aronson, Ph.D : <p>Naomi Aronson: None</p>
• Laurie Fenton Ambrose : <p>Laurie Fenton Ambrose: None</p>
• Bruce Hillner, MD : <p>Bruce Hillner: None</p>
• Cynthia Moran, BA : <p>Cynthia Moran: None</p>